TP53 and invasive carcinoma: In contrast, although high p53 autoantibody levels have been associated with adenocarcinoma and invasive carcinomas, no differences based on clinical stage, overall survival, or disease-free survival were found associated to p53 autoantibodies during the follow-up of CRC patients.